ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 8.97
(-0.44%)
CNY 8.97
(-0.44%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.19 Billion CNY | 57.3% |
| 2022 | 2.03 Billion CNY | -8.76% |
| 2021 | 2.22 Billion CNY | 24.32% |
| 2020 | 1.79 Billion CNY | -6.63% |
| 2019 | 1.91 Billion CNY | 27.59% |
| 2018 | 1.5 Billion CNY | 2.55% |
| 2017 | 1.46 Billion CNY | 43.04% |
| 2016 | 1.02 Billion CNY | 28.07% |
| 2015 | 800.93 Million CNY | 50.34% |
| 2014 | 532.75 Million CNY | -21.12% |
| 2013 | 675.41 Million CNY | 7.67% |
| 2012 | 627.31 Million CNY | 107.08% |
| 2011 | 302.93 Million CNY | -13.45% |
| 2010 | 350.02 Million CNY | 150.83% |
| 2009 | 139.54 Million CNY | -4.13% |
| 2008 | 145.54 Million CNY | 124.29% |
| 2007 | 64.89 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.12 Billion CNY | -2.19% |
| 2024 Q2 | 2.44 Billion CNY | -22.0% |
| 2024 Q3 | 1.72 Billion CNY | -29.51% |
| 2023 Q2 | 1.74 Billion CNY | -29.96% |
| 2023 Q1 | 2.48 Billion CNY | 22.31% |
| 2023 Q3 | 1.35 Billion CNY | -22.45% |
| 2023 Q4 | 3.19 Billion CNY | 136.76% |
| 2023 FY | 3.19 Billion CNY | 57.3% |
| 2022 FY | 2.03 Billion CNY | -8.76% |
| 2022 Q2 | 1.55 Billion CNY | -33.04% |
| 2022 Q3 | 1.01 Billion CNY | -34.82% |
| 2022 Q4 | 2.03 Billion CNY | 101.24% |
| 2022 Q1 | 2.31 Billion CNY | 3.88% |
| 2021 Q3 | 902.1 Million CNY | -30.53% |
| 2021 FY | 2.22 Billion CNY | 24.32% |
| 2021 Q2 | 1.29 Billion CNY | -19.95% |
| 2021 Q1 | 1.62 Billion CNY | -9.51% |
| 2021 Q4 | 2.22 Billion CNY | 147.04% |
| 2020 Q2 | 1.28 Billion CNY | -23.36% |
| 2020 Q3 | 1.02 Billion CNY | -20.6% |
| 2020 FY | 1.79 Billion CNY | -6.63% |
| 2020 Q4 | 1.79 Billion CNY | 75.51% |
| 2020 Q1 | 1.67 Billion CNY | -12.58% |
| 2019 Q2 | 1.17 Billion CNY | -18.75% |
| 2019 FY | 1.91 Billion CNY | 27.59% |
| 2019 Q3 | 993.02 Million CNY | -15.14% |
| 2019 Q4 | 1.91 Billion CNY | 93.34% |
| 2019 Q1 | 1.44 Billion CNY | -4.29% |
| 2018 Q3 | 1.09 Billion CNY | -19.0% |
| 2018 Q1 | 1.46 Billion CNY | -0.34% |
| 2018 FY | 1.5 Billion CNY | 2.55% |
| 2018 Q4 | 1.5 Billion CNY | 37.67% |
| 2018 Q2 | 1.34 Billion CNY | -7.72% |
| 2017 Q3 | 703.95 Million CNY | -18.42% |
| 2017 Q4 | 1.46 Billion CNY | 108.43% |
| 2017 FY | 1.46 Billion CNY | 43.04% |
| 2017 Q1 | 1.04 Billion CNY | 1.62% |
| 2017 Q2 | 862.9 Million CNY | -17.22% |
| 2016 Q4 | 1.02 Billion CNY | 118.68% |
| 2016 Q3 | 469.06 Million CNY | -5.4% |
| 2016 Q2 | 495.84 Million CNY | -27.27% |
| 2016 FY | 1.02 Billion CNY | 28.07% |
| 2016 Q1 | 681.8 Million CNY | -14.87% |
| 2015 Q1 | 570.99 Million CNY | 7.18% |
| 2015 Q3 | 461.38 Million CNY | -3.68% |
| 2015 FY | 800.93 Million CNY | 50.34% |
| 2015 Q4 | 800.93 Million CNY | 73.59% |
| 2015 Q2 | 479.01 Million CNY | -16.11% |
| 2014 Q2 | 539.19 Million CNY | -23.97% |
| 2014 Q4 | 532.75 Million CNY | 38.3% |
| 2014 Q3 | 385.2 Million CNY | -28.56% |
| 2014 Q1 | 709.19 Million CNY | 5.0% |
| 2014 FY | 532.75 Million CNY | -21.12% |
| 2013 Q2 | 619.33 Million CNY | -8.75% |
| 2013 FY | 675.41 Million CNY | 7.67% |
| 2013 Q4 | 675.41 Million CNY | 21.73% |
| 2013 Q3 | 554.85 Million CNY | -10.41% |
| 2013 Q1 | 678.72 Million CNY | 8.19% |
| 2012 Q3 | 554.02 Million CNY | 30.83% |
| 2012 Q4 | 627.31 Million CNY | 13.23% |
| 2012 Q1 | 387.52 Million CNY | 27.92% |
| 2012 FY | 627.31 Million CNY | 107.08% |
| 2012 Q2 | 423.48 Million CNY | 9.28% |
| 2011 Q1 | 364.48 Million CNY | 4.13% |
| 2011 Q2 | 330.94 Million CNY | -9.2% |
| 2011 Q4 | 302.93 Million CNY | 36.4% |
| 2011 FY | 302.93 Million CNY | -13.45% |
| 2011 Q3 | 222.08 Million CNY | -32.89% |
| 2010 Q3 | 88.42 Million CNY | -27.42% |
| 2010 Q4 | 350.02 Million CNY | 295.82% |
| 2010 FY | 350.02 Million CNY | 150.83% |
| 2010 Q2 | 121.84 Million CNY | 0.0% |
| 2009 Q4 | 139.54 Million CNY | 0.0% |
| 2009 FY | 139.54 Million CNY | -4.13% |
| 2008 FY | 145.54 Million CNY | 124.29% |
| 2007 FY | 64.89 Million CNY | 0.0% |